Sign Out
Each capsule contains micronized Fenofibrate 200 mg.
Fenofibrate (ZINOF 200) is a lipid-regulating agent. Fenofibric acid, the active metabolite of Fenofibrate, lowers plasma triglycerides apparently by inhibiting triglyceride synthesis, resulting in reduction of very low density lipoprotein (VLDL) released into the circulation and also by stimulating the catabolism of triglyceride rich lipoprotein (i.e. VLDL). Fenofibrate also reduces serum uric acid levels in hyperuricemic and normal individuals by increasing the urinary excretion of uric acid.
Continue with Google